 - Treatment-naive participants defined as 12 weeks of oral antiviral treatment with any nucleoside or nucleotide analogue OR treatment-experienced participants defined as participants meeting all entry criteria including HBV DNA and serum ALT criteria and with 12 weeks of previous treatment with any nucleoside or nucleotide analogue 